CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-591 Cr | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr | ₹-18 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-591 Cr |
Mar2024 | ₹-403 Cr |
Mar2023 | ₹-293 Cr |
Mar2022 | ₹-205 Cr |
Mar2021 | ₹-18 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-591 Cr | Negative | |
Mar2024 | ₹-403 Cr | Negative | |
Mar2023 | ₹-293 Cr | Negative | |
Mar2022 | ₹-205 Cr | Negative | |
Mar2021 | ₹-18 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,195.4 Cr | -1.7% | 2.3% | -5.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹399,249.0 Cr | -1.3% | -3.3% | 8.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,940.0 Cr | -1.5% | 0.8% | 42.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,618.0 Cr | -1.6% | 8.4% | 10.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,250.0 Cr | -3.3% | -1.4% | 9.8% | Stock Analytics | |
MANKIND PHARMA | ₹94,475.7 Cr | -3.3% | -6.1% | 3.4% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -1.7% |
2.3% |
-5.8% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses